FluLaval and Fluarix vaccines for 2010-2011 influenza season

GlaxoSmithKline announced that it has begun shipping the 2010–2011 formulation of FluLaval (trivalent, inactivated, “split virus” influenza vaccine [Types A and B]) and anticipates distributing Fluarix (trivalent, inactivated, “split virus” influenza vaccine [Types A and B]) in the next several weeks. This season’s FluLaval and Fluarix vaccines will include the 2009 H1N1 pandemic strain among the three vaccine strains. GlaxoSmithKline expects to supply more than 30 million doses combined of FluLaval and Fluarix this flu season.

FluLaval is approved for use in adults ≥18 years of age to help protect against influenza disease. Fluarix is approved for use in adults and children ≥3 years of age.

For more information call (888) 825-5249 or visit us.gsk.com.